Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Gorrell

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
The American Journal of Pathology|March 2, 2011
Discoidin domain receptor 1: isoform expression and potential functions in cirrhotic human liverSunmi Song, Nicholas A Shackel, Xin M Wang, et al.
Clinical and Translational Gastroenterology|January 21, 2022
Circulating Dipeptidyl Peptidase Activity Is a Potential Biomarker for Inflammatory Bowel DiseaseSimone E Jaenisch, Catherine A Abbott, Mark D Gorrell, et al.
Biochimica Et Biophysica Acta|November 18, 2005
Molecular characterization of a novel dipeptidyl peptidase like 2-short form (DPL2-s) that is highly expressed in the brain and lacks dipeptidyl peptidase activityTong Chen, Katerina Ajami, Geoffrey W McCaughan, et al.
Advances in Experimental Medicine and Biology|April 5, 2003
Different inhibition mechanisms of dipeptidyl peptidase IV by tryptophan containing peptides and amidesAngela Stöckel-Maschek, Beate Stiebitz, Jürgen Faust, et al.
Biochemistry|January 22, 2003
Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene familyKaterina Ajami, Catherine A Abbott, Mina Obradovic, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
Fibroblast activation protein and chronic liver diseaseXin Maggie Wang, Tsun-Wen Yao, Naveed A Nadvi, et al.
Journal of Cell Communication and Signaling|January 17, 2022
Targeting CCN2 protects against progressive non-alcoholic steatohepatitis in a preclinical model induced by high-fat feeding and type 2 diabetesJing Ren, Xiaoyu Wang, Sarah N Parry, et al.
Cancers|April 30, 2021
DPP9: Comprehensive In Silico Analyses of Loss of Function Gene Variants and Associated Gene Expression Signatures in Human Hepatocellular CarcinomaJiali Carrie Huang, Abdullah Al Emran, Justine Moreno Endaya, et al.
Advances in Experimental Medicine and Biology|April 5, 2003
Intrahepatic expression of collagen and fibroblast activation protein (FAP) in hepatitis C virus infectionMark D Gorrell, Xin M Wang, Miriam T Levy, et al.
Peptides|December 2, 2015
Neuropeptide Y is a physiological substrate of fibroblast activation protein: Enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinomaPok Fai Wong, Margaret G Gall, William W Bachovchin, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
The American Journal of Pathology|March 2, 2011
Discoidin domain receptor 1: isoform expression and potential functions in cirrhotic human liverSunmi Song, Nicholas A Shackel, Xin M Wang, et al.
Clinical and Translational Gastroenterology|January 21, 2022
Circulating Dipeptidyl Peptidase Activity Is a Potential Biomarker for Inflammatory Bowel DiseaseSimone E Jaenisch, Catherine A Abbott, Mark D Gorrell, et al.
Biochimica Et Biophysica Acta|November 18, 2005
Molecular characterization of a novel dipeptidyl peptidase like 2-short form (DPL2-s) that is highly expressed in the brain and lacks dipeptidyl peptidase activityTong Chen, Katerina Ajami, Geoffrey W McCaughan, et al.
Advances in Experimental Medicine and Biology|April 5, 2003
Different inhibition mechanisms of dipeptidyl peptidase IV by tryptophan containing peptides and amidesAngela Stöckel-Maschek, Beate Stiebitz, Jürgen Faust, et al.
Biochemistry|January 22, 2003
Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene familyKaterina Ajami, Catherine A Abbott, Mina Obradovic, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
Fibroblast activation protein and chronic liver diseaseXin Maggie Wang, Tsun-Wen Yao, Naveed A Nadvi, et al.
Journal of Cell Communication and Signaling|January 17, 2022
Targeting CCN2 protects against progressive non-alcoholic steatohepatitis in a preclinical model induced by high-fat feeding and type 2 diabetesJing Ren, Xiaoyu Wang, Sarah N Parry, et al.
Cancers|April 30, 2021
DPP9: Comprehensive In Silico Analyses of Loss of Function Gene Variants and Associated Gene Expression Signatures in Human Hepatocellular CarcinomaJiali Carrie Huang, Abdullah Al Emran, Justine Moreno Endaya, et al.
Advances in Experimental Medicine and Biology|April 5, 2003
Intrahepatic expression of collagen and fibroblast activation protein (FAP) in hepatitis C virus infectionMark D Gorrell, Xin M Wang, Miriam T Levy, et al.
Peptides|December 2, 2015
Neuropeptide Y is a physiological substrate of fibroblast activation protein: Enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinomaPok Fai Wong, Margaret G Gall, William W Bachovchin, et al.
Pageof 10